Year 2017 / Volume 109 / Number 5
Case Report
Cutaneous necrosis secondary to terlipressin therapy. A rare but serious side effect. Case report and literature review

380-382

DOI: 10.17235/reed.2017.4466/2016

Enrique Iglesias Julián, Ester Badía Aranda, Belén Bernad Cabredo, Daniel Corrales Cruz, María José Romero Arauzo,

Abstract
Terlipressin is a vasopressin analogue used in esophageal variceal bleeding and hepatorenal syndrome management. It is a safe drug with mild secondary effects. However, potentially serious ischemic complications may occur, such as cutaneous necrosis. It is useful to recognize these events early, in order to withdraw terlipressin and introduce other adjuvant drugs if needed. We report a detailed case of cutaneous necrosis secondary to terlipressin administration and present a case review of patients, describing their characteristics, risk factors, lesion locations, doses, methods of administration and possible treatments.
Share Button
New comment
Comments
No comments for this article
References
1. Holmes CL, Landry DW, Granton JT. Science review: Vasopressin and the cardiovascular system part 1--receptor physiology. Crit Care 2003; 7: 427-34.
2. Di Micoli A, Bracci E, Cappa FM et al. Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome. Dig Liver Dis 2008 40: 304-5.
3. Posada C, Feal C, García-Cruz A et al. Cutaneous necrosis secondary to terlipressin therapy. Acta Derm Venereol 2009; 89: 434-5.
4. Yefet E, Gershovich M, Farber E et al. Extensive epidermal necrosis due to terlipressin. Isr Med Assoc J 2011; 13: 180-1.
5. Lu YY, Wei KC, Wu CS. Terlipressin-induced extensive skin necrosis: a case report and published work review. J Dermatol 2012; 39: 866-8.
6. Lee HJ, Oh MJ. A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease. Clin Mol Hepatol 2013; 19: 179-84.
7. Taşliyurt T, Kutlutürk F, Erdemır F et al. Ischemic skin necrosis following terlipressin therapy: report of two cases and review of the literature. Turk J Gastroenterol 2012; 23(6): 788-91.
8. Herrera J, Leiva-Salinas M, Palazón JM et al. Extensive cutaneous necrosis due to terlipressin use. Gastroenterol Hepatol 2015; 38(1): 12-3.
9. Bañuelos Ramírez DD, Sánchez Alonso S, Ramírez Palma MM. Sildenafil in severe peripheral ischemia induced by terlipressin. A case report. Reumatol Clin 2011; 7(1): 59-60.
10. Cavallin M, Piano S, Romaro A et al. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study. Hepatology 2016; 63(3):983-92.
Related articles

Letter

Ischemic skin necrosis secondary to the use of terlipressin

DOI: 10.17235/reed.2020.7467/2020

Citation tools
Iglesias Julián E, Badía Aranda E, Bernad Cabredo B, Corrales Cruz D, Romero Arauzo M. Cutaneous necrosis secondary to terlipressin therapy. A rare but serious side effect. Case report and literature review. 4466/2016


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 960 visits.
This article has been downloaded 390 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 23/05/2016

Accepted: 01/06/2016

Online First: 23/01/2017

Published: 03/05/2017

Article revision time: 5 days

Article Online First time: 245 days

Article editing time: 345 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology